The Exhibition is Full of Excitement and Fans of Pan-Cancer Screening Test

With Medlab Middle East hitting Day 3, not a bit of popularity at HymonBio’s booth diminished.

At the exhibition site, members of HymonBio’s business team introduced their core technology and product advantages in detail. After several rounds of negotiations, the company and several internationally renowned medical companies reached a preliminary cooperation intention and reached several important consensuses on the market promotion of the Pan-Cancer Screening Test Kit.

At 3 pm local time, the Dubai exhibition site welcomed a unique live broadcast. Dr. Tammy Tan started her first live broadcast at this exhibition.

In this live broadcast, she showed the cutting-edge technology and innovative achievements of HymonBio to the global audience—the Pan-Cancer Screening Test Kit. Her company uses brand-new logical biotechnology combined with AI algorithms for product development and has made major breakthroughs in the field of pan-tumor research. Only one tube of blood is needed to detect 28 common cancers.

Currently, HymonBio is applying for the U.S. FDA’s Global Breakthrough Innovation Certification based on this innovative technology, and it is expected to be obtained in the next 6 months or so.

The excitement is not over yet,

We are waiting for you at booth Z3. G18!